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ABSTRACT
Objectives: To determine whether humour therapy
reduces depression (primary outcome), agitation and
behavioural disturbances and improves social
engagement and quality-of-life in nursing home
residents.
Design: The Sydney Multisite Intervention of
LaughterBosses and ElderClowns study was a single-
blind cluster randomised controlled trial of humour
therapy.
Setting: 35 Sydney nursing homes.
Participants: All eligible residents within geographically
defined areas within each nursing home were invited to
participate.
Intervention: Professional ‘ElderClowns’ provided
9–12 weekly humour therapy sessions, augmented by
resident engagement by trained staff ‘LaughterBosses’.
Controls received usual care.
Measurements: Depression scores on the Cornell
Scale for Depression in Dementia, agitation scores on the
Cohen-Mansfield Agitation Inventory, behavioural
disturbance scores on the Neuropsychiatric Inventory,
social engagement scores on the withdrawal subscale of
Multidimensional Observation Scale for Elderly Subjects,
and self-rated and proxy-rated quality-of-life scores on a
health-related quality-of-life tool for dementia, the
DEMQOL. All outcomes were measured at the participant
level by researchers blind to group assignment.
Randomisation: Sites were stratified by size and level
of care then assigned to group using a random number
generator.
Results: Seventeen nursing homes (189 residents)
received the intervention and 18 homes (209 residents)
received usual care. Groups did not differ significantly
over time on the primary outcome of depression, or on
behavioural disturbances other than agitation, social
engagement and quality of life. The secondary outcome
of agitation was significantly reduced in the intervention
group compared with controls over 26 weeks (time by
group interaction adjusted for covariates: p=0.011). The
mean difference in change from baseline to 26 weeks in
Blom-transformed agitation scores after adjustment for
covariates was 0.17 (95% CI 0.004 to 0.34, p=0.045).
Conclusions: Humour therapy did not significantly
reduce depression but significantly reduced agitation.
Trial registration: Australian New Zealand Clinical Trials
Registry -ACTRN12611000462987.
ARTICLE SUMMARY
Article focus
▪ The Sydney Multisite Intervention of LaughterBosses
and ElderClowns (SMILE) study is a cluster rando-
mised controlled trial evaluating the effect of humour
therapy on depression, agitation, behavioural distur-
bances, social engagement and quality-of-life in
nursing home residents.
Key messages
▪ Humour therapy was not shown to impact on
depression (main outcome), behavioural distur-
bances other than agitation, social engagement
or quality-of-life.
▪ Humour therapy was successful in reducing agi-
tation in the intervention at 13-week and
26-week follow-up relative to controls who
received usual care.
▪ Humour therapy should be considered as a psy-
chosocial intervention to reduce agitation, before
starting medication.
Strengths and limitations of this study
▪ SMILE offered a novel model of humour therapy
that combined staff training (LaughterBosses)
and 12 visits by professional performers
(ElderClowns).
▪ The sample size was large involving 398 resi-
dents living in 35 Sydney nursing homes: 17
homes in the intervention group and 18 in the
usual care group.
▪ Data collection staff were unblinded to treatment
allocation in 15 of the 35 homes.
▪ There was variation in the number of ElderClown
visits and LaughterBoss initiated humour
received by individual residents.
▪ The study had lower power to detect effects than
expected due to higher than expected intracluster
correlations.
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INTRODUCTION
Humour is a fundamental form of social play with many
psychological beneﬁts: facilitating positive emotions that
in turn may increase problem solving and memory efﬁ-
ciency; facilitating social communication, social inﬂu-
ence and bonding and tension relief and coping with
anxiety.1 Humour therapy involves using humour to
facilitate laughter and happiness. The humour can be
delivered by an individual (eg, by a clown) or recorded
stimuli (eg, a video) or participants can be shown how
to generate humour themselves. Anecdotally, humour
interventions result in positive outcomes; however, the
research evidence is limited. Small experimental studies
with randomised or quasi-randomised designs have
reported beneﬁcial effects of humour interventions on a
diverse range of outcomes, such as: pregnancy rates
during in vitro fertilisation,2 reducing preoperative
anxiety in children,3 lowering diastolic blood pressure,
respiratory frequency and temperature in children with
respiratory pathologies,4 and in decreasing depression
and insomnia in older persons.5 6 While people living
with dementia appreciate and can express themselves
with humour,7 8 there are seldom opportunities to
experience humour when living in a nursing home.9
Five of the six studies evaluating the efﬁcacy of
humour therapy in nursing home residents reported
some beneﬁt,10–15 albeit limited by small sample sizes,
relatively low-quality methodology and lack of ﬂexibility
in matching humour techniques to residents’ abilities
and preferences.10 15 A non-controlled study (n=21) of
four clown sessions, evaluated using a modiﬁed demen-
tia care mapping protocol, found an overall increase in
positive behaviours and decrease in negative behaviours
during the sessions in persons with severe dementia;
however, there was no follow-up outside the sessions.10 A
non-randomised controlled study (n=61) found that ﬁve
sessions of comical singing and dancing were associated
with decreased self-rated anxiety and depression in
nursing home residents.11 Fortnightly group humour
therapy for psychiatric in-patients with either
Alzheimer’s disease, or late-life depression, did not
improve quality-of-life for either group in addition to
standard pharmacotherapy (n=20).15 Nursing home resi-
dents (n=87) randomly assigned to watch humorous
movies three times a week showed decreased negative
affect following the 12-week intervention compared with
both those residents who watched serious movies and
controls who received usual care.12 Residents (n=27)
randomly assigned to watch recordings of humorous
story-telling weekly for 12 weeks reported improved
quality-of-life compared to those who watched conven-
tional television and those who received usual care.13
Eight weekly sessions involving telling jokes, and funny
stories and discussions on prioritising humour in daily
life decreased reports of pain and perceived loneliness,
and increased reported happiness and life satisfaction in
residents in the intervention group (n=36) compared
with controls (n=34).14
The primary aim of the Sydney Multisite Intervention of
LaughterBosses and ElderClowns (SMILE) (Australian
New Zealand Clinical Trials Registry number
ACTRN12611000462987) was to evaluate the effectiveness
of humour therapy in improving mood in individual resi-
dents living in nursing homes. Secondary aims were to
investigate the effectiveness of humour therapy on decreas-
ing agitation and other behavioural disturbances, and
increasing quality-of-life and social engagement of resi-
dents. We utilised a clustered design with randomisation at
the facility level as the intervention involved training staff to
change their behaviour towards residents, which is difﬁcult
to contain to only certain residents within their care.
METHODS
A single-blind two-group longitudinal cluster rando-
mised controlled design was used in SMILE to evaluate
humour therapy in Australian nursing homes. The Study
protocol details have been reported previously.16 Ethics
approval was obtained from the University of New South
Wales Human Research Ethics Committee (approval
number 08345). Residents either provided written
consent, if judged by the researcher as being able to
understand information about the study and make an
informed decision about participation, or verbal assent,
if incapable of providing written consent, with written
consent obtained from a proxy.
Participants
Invitations were made to 228 nursing homes located in
Sydney, Australia. Eligible homes were: government
accredited; located within greater metropolitan Sydney
within 1 h drive from the University of New South Wales,
Sydney; not enrolled in another intervention study; not
catering for particular ethnic and minority groups or
medical conditions except for dementia; not scheduled
for change in management, renovation or programme
delivery; able to secure site-speciﬁc governance permis-
sion and in agreement with study terms. After screening,
the ﬁrst 36 eligible homes were randomised to an inter-
vention or a control group. Eight additional eligible
homes on a waiting list replaced homes that withdrew
before baseline. One home that began the intervention
and was subsequently found to be ineligible because it
catered speciﬁcally to persons with mental illnesses and
drug and alcohol addiction was immediately excluded.
Data collection occurred in six rolling cycles between
July 2009 and May 2011.
Within each home, a geographical SMILE neighbour-
hood was deﬁned following discussion with facility man-
agers. Criteria were that the area accommodated <40
residents, and permitted interaction between residents
and the staff member to be trained in humour therapy.
All eligible residents within SMILE neighbourhoods
were invited to participate. Residents were ineligible if
they were <50 years of age, admitted to full-time care
<12 weeks prior, exhibiting behaviour presenting a risk to
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study personnel, foreshadowed to move out of the SMILE
neighbourhood within 6 months, experiencing severe
communication obstacles, acutely unwell, under public
guardianship with no person responsible to consent on
their behalf, or if they had ﬂorid psychiatric symptoms or
a known fear of clowns or strangers (see ﬁgure 1).
Intervention
The humour therapy intervention comprised two
components:
1. One-day LaughterBoss training for each home’s
nominated staff member.17 Training covered the evi-
dence linking humour and health, and practical ways
for including humour in daily care. LaughterBosses
assisted during ElderClown visits and were encour-
aged to continue the humour intervention between
and after ElderClown visits.
2. Between 9 and 12 humour therapy sessions by an
ElderClown;18 a trained performer experienced in
healthcare settings, who at each session visited with
available and willing residents enrolled in the study.
Figure 1 Pattern of nursing home (NH) and resident recruitment and participation.
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ElderClowns tailored their interactions to maximise
resident engagement, laughter and enjoyment, adapt-
ing to the background, personality, mood and phys-
ical and cognitive abilities of the resident.
ElderClowns prepared for their work with individual
residents, and also improvised based on the residents’
reactions and to make the conversation and inter-
action light hearted and playful. Interactions could
be based around music—serenading the resident
with their favourite song, or adapting a song to
include their name, encouraging them to dance with
each other or the LaughterBoss; could involve asking
the resident’s advice about a problem that the
ElderClown has such as whether to buy a cat or a
dog, or be based around jokes relating to a prop
such as a slip-on rubber thumb with a light at the
end. Interactions could occur in groups and individu-
ally depending on the resident’s preferences.
For instance, a female resident with moderate demen-
tia might have been engaged by an ElderClown asking
her opinion about which hat would suit her best. Hats
varied from a formal dress hat, to a sailor’s hat to a silly
costume hat with attached wig. The resident laughed at
how the ElderClown looked in the hats and at her expres-
sions and comments when wearing them, and made
some joking comments about the hats. A male resident
with severe dementia might have been engaged with a
game of pretend tennis using plastic rackets and a ball on
a wire. The LaughterBoss held one racket, the resident
held the other and the ElderClown controlled the ball,
making it easier or more difﬁcult for the players to hit
the ball, and also providing exaggerated commentary on
the game. The resident tried to hit the ball, tracking it
visually and smiled when he succeeded and was praised
in the Elderclown’s commentary. Information about resi-
dents was obtained from resident charts and presession
brieﬁngs by the LaughterBoss. Postsession debrieﬁng ses-
sions between the ElderClown and LaughterBoss
involved a discussion on what did and did not work, and
formulation of ideas for the next visit. The trailer of a
documentary showing ElderClown visits ﬁlmed during
SMILE is available at http://thesmilewithin.com.au/.
Randomisation and masking
Enrolled homes were assigned a study number by the
administrative assistant and deidentiﬁed characteristics
were used for randomisation by the ﬁrst author. SMILE
neighbourhoods were stratiﬁed by size (<25 beds vs ≥25
beds) and care level (high care vs low care). A random
number generator in Excel was used to assign homes to
intervention and control groups.
Only one investigator (LFL) and the administrative
assistant were aware of treatment allocation before base-
line assessment at each facility. Nursing homes and
humour intervention staff were notiﬁed of treatment
group by the administrative assistant after baseline.
Reminders were given to nursing home staff prior to
each occasion of contact to maintain blinding of data
collectors. Nevertheless nursing home staff, residents or
families revealed the blinding for 15 separate homes (5
control, 10 intervention) to one or two data collection
staff, the remaining three data collection staff remained
blinded throughout.
Assessment
Data were collected at three time points: baseline (week 0),
post (week 13) and follow-up (week 26). Information was
collected from the resident (if able and willing), a reliable
staff informant, direct observation and from clinical ﬁles.
The primary outcome measure was The Cornell Scale
for Depression in Dementia (CSDD) which is a clinician-
rated depression scale.19 Secondary outcome measures
were: the Cohen-Mansﬁeld Agitation Inventory (CMAI)20
and the Neuropsychiatric Inventory Nursing Home21 to
obtain informant ratings of the severity and frequency of
12 behavioural disturbances to assess informant-rated fre-
quency of agitated behaviours; the eight-item withdrawal
subscale of the Multidimensional Observation Scale for
Elderly Subjects (MOSES) to measure informant rated
social engagement,22 and the DEMQOL to provide proxy
and self-rated measure of health-related quality of life.23
In addition, demographic information was collected, func-
tional impairment was assessed using the Barthel Index,24
relative severity of dementia was rated using the Global
Deterioration Scale,25 and the appropriateness of the phys-
ical environment for nursing home residents was rated at
the facility level using the Environmental Audit Tool.26
After each ElderClown visit, the LaughterBoss and
ElderClown independently completed global ratings of the
level of success in engaging each resident on a 10-point
scale (1=extremely unsuccessful to10=extremely successful).
Analyses
A sample size of 36 homes with 9–10 residents in each was
estimated to provide over 80% power to detect a medium
effect size (Cohen’s d=0.5) difference on continuous out-
comes with signiﬁcance level set at two-sided 0.05,27 based
on intraclass correlations on the outcome measures
obtained from a previous multisite nursing home study.28
Analyses were conducted on an intention-to-treat basis
by a statistician blind to group allocation using
intention-to-treat analysis in SAS V.9.2 software.29 The α
for signiﬁcance was set at p=0.05 for all analyses, such
that we had 5% chance of incorrectly rejecting the null
hypothesis for each test. Baseline differences in charac-
teristics and outcome measures between groups were
examined using t tests for normally distributed continu-
ous data, χ2 tests for categorical data or Mann-Whitney
U tests for non-normally distributed continuous data.
Restricted maximum likelihood-based multilevel linear
mixed models were employed to estimate the interven-
tion effect, taking into account both within-resident cor-
relation (repeated measures) and within-cluster (nursing
home) correlation of the endpoints via random effect
speciﬁcation.30 Baseline response was adjusted using an
approach recommended by Fitzmaurice et al.31 All
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outcome measures were continuous, and data from all
three time points were included as endpoints in the
model. Intervention by time interaction was estimated to
test for global group differences and for global change
over time between groups. Potential confounding charac-
teristics of homes and residents were included as cluster-
level or individual-level ﬁxed or time-varying covariates
and retained if evidence of confounding occurred (ie, if
estimates of treatment effect differed substantially in the
adjusted vs unadjusted models, or they explained signiﬁ-
cant variation in the outcomes). The Blom transform-
ation was used to account for data skewness.32
The effect of engagement dose on outcomes was
explored further within the intervention group. Dose
was calculated as the total of engagement score for all
visits, averaged across LaughterBoss and ElderClown
ratings which were highly correlated (r(1475)=0.863,
p<0.001). Statistical analysis was conducted in a similar
manner to the primary analysis as outlined above.
RESULTS
Figure 1 shows trial recruitment and participant ﬂow to
achieve the ﬁnal analysis sample of 209 usual care control
group residents from 18 homes (7 low care, 11 high care)
and 189 humour therapy group residents from 17 homes
(7 low care, 10 high care). Baseline characteristics of the
intervention and control groups are shown in Table 1.
There were no signiﬁcant differences on demographic
characteristics between the groups. Intervention group
residents were taking slightly more regular psychotropic
medications on average and were rated by staff as having
higher levels of agitation on the CMAI.
A total of 191 humour therapy sessions were delivered
(average of 11, SD=1 per facility), with individual resi-
dents receiving an average of 9 (SD=3) ElderClown visits.
Table 2 shows the raw mean scores by group and the
three assessment occasions for the ﬁve resident outcome
measures, the model adjusted mean difference in change
between groups, and the primary analysis results.
Depression and social engagement decreased and
resident-rated dementia quality-of-life increased over time,
but the group by time interactions on depression, non-
agitation behavioural disturbance, social engagement or
resident-rated or proxy-rated quality-of-life were non-
signiﬁcant (p>0.05). The group-by-time interaction was
signiﬁcant for agitation measured using the CMAI, before
and after adjustment for covariates (p<0.05). The adjusted
mean differences of change based on Blom-transformed
scores indicates that the humour therapy group decreased
on the CMAI by 0.17 (95% CI 0.004 to 0.34; p=0.045)
points more than controls between baseline and follow-up,
Table 1 Baseline characteristics of residents and SMILE neighbourhoods by group
Usual care controls (n=209,
18 facilities)
Humour therapy (n=189,
17 facilities) Test statistic
SMILE neighbourhoods
Number of residents 22.1±8.6 19.1±7.7 t(33)=1.08, p=0.29
Number of residents who
participated
10.8±3.3 11.3±2.3 t(33)=0.67, p=0.51
Residents
Age in years 84.5±8.7 84.5±7.5 t(396)=−0.09, p=0.93
Number of females 161 (77.0%) 146 (77.2%) Χ2 (1)=0.00, p=0.96
Number with dementia diagnoses
in chart
165 (78.9%) 145 (76.7%) Χ2(1)=0.29, p=0.59
Years lived in care 2.7±2.8 2.8±3.1 U=19153.0, p=0.66
Global Deterioration Scale 5.0±1.2 5.0±1.2 U=19573.0, p=0.87
Number with English as a first
language
204 (97.6%) 186 (98.4%) Χ2(1)=0.32, p=0.57
Number of regular psychotropic
medications
1.0±1.0 1.2±1.0 U=17484.0, p=0.045
Barthel 41.5±24.5 42.3±25.2 U=19397.5, p=0.76
Cornell Scale for Depression in
Dementia
7.8±5.6 8.5±6.1 U=18565.5, p=0.34
Cohen-Mansfield Agitation
Inventory
38.9±11.0 45.3±20.0 U=16897.0, p=0.012
Neuropsychiatric Inventory 18.7±16.9 22.3±21.7 U=18771.5, p=0.39
DEMQOL-resident 89.9±13.8 89.4±15.5 U=8818.5, p=0.89
DEMQOL-proxy 106.0±13.4 103.5±11.1 U=17266.0, p=0.075
MOSES social engagement
subscale
18.1±6.2 17.4±6.0 U=18401.5, p=0.24
Figures are means and SDs of scores unless otherwise stated.
SMILE, Sydney Multisite Intervention of LaughterBosses and ElderClowns; MOSES, Multidimensional Observation Scale for Elderly
Subjects.
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Table 2 Effect of humour therapy on outcome measures over time at resident level
Baseline
(n=398)* Post (n=371)*
Follow-up
(n=343)*
Adjusted mean
difference
baseline-post (95%
CI) p Value
Adjusted mean difference
baseline-follow-up (95%
CI) p Value
Intracluster
correlation
coefficient
Depression (CSDD) pG=0.68, pT<0.01, pGT=0.88; pGc=0.50, pTc<0.01, pGTc=0.89
Control 7.8±5.6 6.5±4.5 6.3±5.4 0.006 (−0.19 to 0.20) 0.95 0.046 (−0.18 to 0.27) 0.69 0.12
Intervention 8.5±6.1 6.9±5.2 6.4±4.8
Agitation (CMAI) pG=0.33, pT=0.22, pGT=0.01; pGc=0.20, pTc=0.02, pGTc=0.01
Control 38.9±11.0 37.9±10.0 39.0±11.7 −0.04 (−0.18 to 0.11) 0.61 0.17 (0.004 to 0.34) 0.045 0.15
Intervention 45.3±20.0 43.4±19.1 42.0±18.3
Behavioural
disturbance (NPI)
pG=0.69, pT=0.63, pGT=0.07; pGc=0.47, pTc=0.49, pGTc=0.09
Control 18.7±16.9 19.3±15.7 18.1±16.8 0.05 (−0.11 to 0.22) 0.52 −0.15 (−0.34 to 0.04) 0.13 0.18
Intervention 22.3±21.7 20.0±20.3 23.2±22.0
Social engagement
(MOSES)
pG=0.44, pT<0.01, pGT=0.62; pGc=0.41, pTc<0.01, pGTc=0.45
Control 18.2±6.0 18.2±6.0 18.7±6.3 −0.046 (−0.21 to 0.12) 0.58 0.049 (−0.13 to 0.22) 0.59 0.12
Intervention 17.3±6.0 17.6±6.4 18.1±6.1
Resident-rated quality
of life (DEMQOL-res)
pG=0.72, pT<0.01, pGT=0.29; pGc=0.51 pTc=<0.01, pGTc=0.41
Control 89.9±13.8 92.9±12.7 92.5±15.4 −0.10 (−0.31 to 0.11) 0.34 0.05 (−0.18 to 0.28) 0.67 0.06
Intervention 89.4±5.5 93.7±13.1 92.0±14.0
Staff-rated
quality-of-life
(DEMQOL-proxy)
pG=0.13, pT=<0.01, pGT=0.44; pGc=0.11, pTc=<0.01, pGTc=0.40
Control 106.0±13.4 104.5±16.3 103.2±11.8 0.07 (−0.16 to 0.31) 0.53 −0.07 (−0.28 to 0.13) 0.48 0.40
Intervention 103.5±11.1 100.6±14.9 101.4±11.7
Adjusted mean scores are based on the standardised (Blom-transformed) scores. Positive scores indicate improvement.
p Values from mixed models with all three time points included as outcomes but no covariates: pG is for main effect of intervention, pT is for main effect of time, pGT is interaction of group×time.
p Values for mixed models including significant covariates: pGc is for main effect of intervention, pTc is for main effect of time, pGTc is interaction of group×time.
Significant covariates for CSDD were age, GDS, Barthel and time in care; for CMAI were age and GDS; for NPI were age, GDS, dementia diagnosis; for MOSES were gender, GDS, Barthel; for
DEMQOL-res were Barthel, and time in care; for DEMQOL-proxy was time in care.
*Data are raw non-transformed scores.
CMAI, Cohen-Mansfield Agitation Inventory; CSDD, Cornell Scale for Depression in Dementia; GDS, Global Deterioration Scale; NPI, Neuropsychiatric Inventory.
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the difference in raw scores was 2.52 (95% CI 0.20 to 5.32,
p=0.07). The difference in change from post to follow-up
on the CMAI was statistically signiﬁcant with the adjusted
mean difference being 0.21 (95% CI 0.07 to 0.35;
p=0.003) the difference in raw scores was 2.95 (95% CI
0.89 to 5.02, p=0.005). There were signiﬁcant engagement
dose-by-time interactions for depression (F(2,496)=6.72,
p=0.00), behavioural disturbance (F(2, 497)=3.49, p=0.03)
and resident-rated quality-of-life (F(2,337)=3.39, p=0.03),
but not for the other outcome measures. Residents who
experienced higher doses of engagement showed greater
improvement on depression, behavioural disturbance and
resident-rated quality-of-life.
No adverse events were reported after ElderClown ses-
sions or generally in relation to humour therapy with
LaughterBosses.
DISCUSSION
While there was no signiﬁcant beneﬁt on the primary
outcome measure, depression, agitation levels decreased
signiﬁcantly over time with humour therapy compared
with usual care with the mean adjusted change differ-
ence between baseline and follow-up being 2.52 points
—this would be equivalent to two agitated behaviours
decreasing in frequency from daily to once a week.
Difference between treatment and control groups on
change scores on the CMAI pooled across three rando-
mised controlled trials of risperidone were 3. (95% CI
1.78 to 4.22).33 In decreasing agitation, humour therapy
had a similar effect to risperidone, the most commonly
used antipsychotic in Australia for the treatment of
behavioural disturbance in dementia.34 Humour therapy
showed none of the side effects of risperidone. When
adjustments were made for the ‘dosage’ of humour
therapy engagement, humour therapy demonstrated
beneﬁts on depression, behavioural disturbance and self-
reported dementia quality-of-life effects not reported
with medication.
The strengths of SMILE include: a large sample, clus-
tered design and relatively high follow-up rates. We were
able to implement our intervention in real-world nursing
homes, despite initial reservations from some managers
and staff. The sustained beneﬁts in agitation at follow-up
underscore the importance of recruiting staff members
into the programme. Limitations are noted. First, data
collection staff became ‘unblinded’ over time for 15 of
the 35 homes despite constant reminders to nursing
home staff ahead of data collection periods of the import-
ance of maintaining conﬁdentiality of intervention allo-
cation. Second, participating homes might not have been
representative of Australian nursing homes. Compared
with national data, residents in our sample were similar
in average age and dependency level, but were 6% more
likely to be female, required less help with activities of
daily living and had higher levels of behavioural distur-
bances. Third, there were variations between residents in
the number of ElderClown sessions they received, and
variations between homes in the amount of humour
initiated by LaughterBosses outside ElderClown sessions.
LaughterBosses were not tested for competency in deli-
vering humour. Fourth, the two groups were unbalanced
at baseline on several outcome measures, these differ-
ences were adjusted for in our statistical modelling. Fifth,
adjustment for multiple comparisons was not made to
the α for signiﬁcance, as outcome measures were corre-
lated. Sixth, the intracluster correlations for this sample
were much higher than reported in the study on which
our power calculations were based, which resulted in
lower power than planned.
Several explanations are possible for the lack of effect
on outcome measures other than CMAI agitation.
Depression, other forms of behavioural disturbances
and self-rated quality-of-life all improved more in resi-
dents who experienced higher doses of engagement as a
result of humour therapy, suggesting that humour
therapy does change these outcomes, even though there
was not a statistical advantage of intervention over
control groups. There was a ﬂoor effect: only 29% of
our sample was assessed as having probable or possible
depression on the CSDD, and 28% of our sample was
rated as not having any agitation symptoms on the
CMAI, thereby limiting the potential for improvement.
The DEMQOL was developed for persons with mild to
severe dementia; however, 33% of residents were unable
to complete the self-report version. While we interviewed
staff members who knew the resident well, it was difﬁcult
for staff to be aware of the quality-of-life related con-
cerns of many residents, particularly those with poor
verbal skills. Our data and others showed that DEMQOL
proxy scores correlate only mildly or moderately with
DEMQOL self-report. The measures used might not
have been sensitive to anecdotally reported positive
effects such as increased positive mood, and increased
initiation of and participation in social activities.
We offered a novel model of humour therapy delivery
combining staff training (LaughterBosses) and profes-
sional humour therapists (ElderClowns). This was
designed to minimise costs and deliver sustainable practice
change within nursing homes. We believe that the active
ingredients of the programme are engagement and play.
This is supported by our engagement dose analyses and
consistent with a needs-driven behaviour explanatory
model of behaviours.35 Increasing social contact and
opportunities for play could have fulﬁlled a need for
stimulation which is expressed through agitation. Other
tailored models of engaging and stimulating residents
might also be successful.36 Challenges in delivering the
programme predominantly related to false expectations
that, rather than attempting to elicit individual responses
from residents enrolled in the study, the ElderClown
would perform for any audience. Some suggest that the
label ‘ElderClown’ might not be appropriate in describing
the work of the professional performers.
SMILE demonstrated that there are beneﬁts to
increasing positive interactions for residents. If our
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results are replicated, consideration should be given to sys-
tematically introducing humour therapy as a psychosocial
intervention to reduce the level of agitation in nursing
home residents. More research is needed into the efﬁcacy
of different models of delivering humour therapy.
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